Overview

A Single Dose Study to Investigate the Pharmacokinetics of MK-0941 in Participants With Renal Insufficiency (MK-0941-015-02)

Status:
Terminated

Trial end date:
2009-09-01

Target enrollment:

Participant gender:

Summary

This study will assess the pharmacokinetics of MK-0941 in participants with varying degrees of renal insufficiency.

Phase:

Phase 1

Details

Lead Sponsor:

Merck Sharp & Dohme Corp.